🎯 check MDV3100 (Enzalutamide) product page
MDV3100 (Enzalutamide) is a potent androgen receptor antagonist. It affects AR, MAPK, and mTOR signaling pathways, by blocking AR nuclear translocation and transcriptional activity, thereby inhibiting prostate cancer cell proliferation and promoting apoptosis.